Overview

Drug-drug Interaction Study of Digoxin and AT-527 (R07496998)

Status:
Not yet recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
Drug-drug interaction study of Digoxin and AT-527 (R07496998)
Phase:
Phase 1
Details
Lead Sponsor:
Atea Pharmaceuticals, Inc.
Collaborator:
Hoffmann-La Roche
Treatments:
Digoxin